Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
2009/11/12 by Nicholas A. Jones, Andrew J. Hill, Imogen Smith +6 · 27 citations
Medicine · Neuroscience · #Cannabis and Cannabinoid Research #Neuroscience and Neuropharmacology Research #Sleep and Wakefulness Research
paper · pdf · doi:10.1124/jpet.109.159145
Citations
Cited by
- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
- Cannabidiol Pretreatment Reduces Status Epilepticus and Glutamate Uptake Induced by Kainic Acid in Adult Zebrafish
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. [europepmc]
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. [europepmc]
- Cannabidiol in humans-the quest for therapeutic targets. [europepmc]
- Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. [europepmc]
- Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. [europepmc]
- Cannabinoids and Epilepsy. [europepmc]
- Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence. [europepmc]
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection. [europepmc]
- Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid. [europepmc]
- An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. [europepmc]
- Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? [europepmc]
- A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. [europepmc]
- Cannabis Therapeutics and the Future of Neurology. [europepmc]
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial. [europepmc]
- Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study. [europepmc]
- A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects. [europepmc]
- Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination. [europepmc]
- Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects. [europepmc]
- Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. [europepmc]
- Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States. [europepmc]
- Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. [europepmc]
- Industrial Hemp ( Cannabis sativa subsp. sativa ) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals. [europepmc]
- Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease. [europepmc]
- A Review of Hemp as Food and Nutritional Supplement. [europepmc]
- THC and CBD: Similarities and differences between siblings. [europepmc]